Chemical activators of JNK1/MAPK8 associated membrane protein like can initiate their effects through various intracellular signaling pathways. Anisomycin, for example, inhibits protein synthesis, leading to the activation of stress-activated protein kinase/c-Jun pathways that directly activate this protein. Similarly, Fluoride at high concentrations acts as a potent activator of p38 MAP kinase. This activation is part of the cellular stress response pathways that include the stimulation of JNK1/MAPK8 associated membrane protein like. Tetradecanoylphorbol Acetate (TPA) triggers protein kinase C (PKC), which activates the JNK pathway, culminating in the activation of the protein. Thapsigargin contributes to this cascade by increasing cytosolic calcium levels, which activate multiple signaling pathways, including the MAPK pathways that lead to JNK1/MAPK8 associated membrane protein like activation.
Continuing this cellular signaling cascade, okadaic acid and sodium orthovanadate, both phosphatase inhibitors, prevent the dephosphorylation within the MAPK pathway, which sustains JNK1/MAPK8 associated membrane protein like activity. Calyculin A operates in a similar manner to okadaic acid, inhibiting phosphatases and leading to persistent activation of the JNK pathway. U46619, a thromboxane A2 analogue, activates MAPK pathways, including JNK, leading to the activation of the protein. Sphingosine, through its activation of sphingosine kinase, influences cellular stress responses that activate JNK1/MAPK8 associated membrane protein like. Furthermore, arachidonic acid is metabolized into eicosanoids, which activate MAPK signaling pathways and subsequently JNK1/MAPK8 associated membrane protein like. Dibutyryl-cAMP, a cAMP analog, activates PKA, which then leads to the activation of the protein through phosphorylation of CREB and downstream signaling. Lastly, the Epidermal Growth Factor triggers its receptor, which sets off a cascade of intracellular signaling that includes MAPK pathway activation, ultimately leading to the engagement of JNK1/MAPK8 associated membrane protein like.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that leads to the activation of JNK1/MAPK8 associated membrane protein like through the activation of stress-activated protein kinase/c-Jun pathways. It specifically activates JNK signaling which is a direct activator of the protein. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
TPA activates protein kinase C (PKC), which is known to lead to the activation of the JNK pathway and subsequently JNK1/MAPK8 associated membrane protein like. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin causes an increase in cytosolic calcium levels, which can activate multiple signaling pathways including JNK1/MAPK8 associated membrane protein like through MAPK pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a phosphatase inhibitor that prevents dephosphorylation of proteins within the MAPK pathway, thereby sustaining the activation of JNK1/MAPK8 associated membrane protein like. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a phosphatase inhibitor that can enhance JNK pathway activation by preventing dephosphorylation, leading to the activation of JNK1/MAPK8 associated membrane protein like. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, similar to okadaic acid, inhibits phosphatases and thus can lead to the sustained activation of the JNK pathway and consequently JNK1/MAPK8 associated membrane protein like. | ||||||
U-46619 | 56985-40-1 | sc-201242 sc-201242A | 1 mg 10 mg | $245.00 $1301.00 | 40 | |
U46619 is a thromboxane A2 analogue which can activate MAPK pathways including JNK, thereby leading to the activation of JNK1/MAPK8 associated membrane protein like. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
Sphingosine can activate sphingosine kinase, which is involved in the signaling pathways that lead to the activation of JNK1/MAPK8 associated membrane protein like through its effects on cellular stress responses. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Arachidonic acid can be metabolized into various eicosanoids, which are known to activate MAPK signaling pathways that include the JNK pathway, thereby activating JNK1/MAPK8 associated membrane protein like. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, can activate PKA which then can lead to the activation of JNK1/MAPK8 associated membrane protein like through cAMP response element-binding protein (CREB) phosphorylation and downstream signaling. | ||||||